Diabetes Drug Actos May Increase Bladder Cancer Odds

<p>THURSDAY, May 31 (HealthDay News) People with type 2 diabetes
taking Actos (pioglitazone) to control blood sugar might put themselves at
risk for bladder cancer, according to a new Canadian study.
Although a comprehensive risk of anyone building bladder cancer remains
very low, holding a Actos tablet for dual years can double a risk, the
researchers said.
We trust physicians, patients and regulatory agencies should be
aware of this organisation when assessing a altogether risks and advantages of
this therapy, pronounced lead researcher Laurent Azoulay, from a Center for
Clinical Epidemiology during a Lady Davis Institute during Jewish General
Hospital in Montreal.
The organisation between a use of pioglitazone and bladder cancer is
controversial, with several studies stating opposing results, from
modest increasing risks to no association, pronounced Azoulay, who also is an
assistant highbrow in a oncology dialect during McGill University in
Montreal.
The news was published...